Marshall Wace’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11M Buy
+742,725
New +$11M 0.01% 730
2024
Q4
Sell
-111,341
Closed -$1.56M 2811
2024
Q3
$1.56M Buy
+111,341
New +$1.56M ﹤0.01% 1348
2023
Q4
Sell
-73,332
Closed -$656K 2298
2023
Q3
$656K Buy
+73,332
New +$656K ﹤0.01% 1372
2023
Q2
Sell
-214,498
Closed -$4.82M 2514
2023
Q1
$4.82M Buy
+214,498
New +$4.82M 0.01% 860
2022
Q1
Sell
-6,866
Closed -$213K 3329
2021
Q4
$213K Sell
6,866
-45,441
-87% -$1.41M ﹤0.01% 2462
2021
Q3
$1.27M Buy
+52,307
New +$1.27M 0.01% 1442
2021
Q2
Sell
-174,193
Closed -$4.35M 2565
2021
Q1
$4.35M Buy
+174,193
New +$4.35M 0.02% 822
2020
Q3
Sell
-98,976
Closed -$2.02M 1892
2020
Q2
$2.02M Buy
+98,976
New +$2.02M 0.01% 768
2016
Q3
Sell
-90,194
Closed -$1.61M 1134
2016
Q2
$1.61M Buy
90,194
+71,952
+394% +$1.28M 0.01% 620
2016
Q1
$249K Buy
+18,242
New +$249K ﹤0.01% 950